Shots:

• Roche’s cobas SARS-CoV-2 test to be use on high-throughput cobas 6800/8800 systems has received the US FDA’s EUA for testing individuals without symptoms or reasons to control the spread of COVID-19
• The authorization expands SARS-CoV-2 testing to include people without symptoms and applies to pooled samples containing up to and including 6 individual samples
• Asymptomatic testing with the cobas SARS-CoV-2 test is available in countries accepting the CE mark

  Ref: PR Newswire | Image: Roche